{"title":"Epithelial ovarian, fallopian tube and primary peritoneal cancer: an overview","authors":"Jane Borley","doi":"10.1016/j.ogrm.2023.10.004","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Ovarian, fallopian tube and </span>primary peritoneal cancer<span> has the poorest survival outcomes of all gynaecological malignancies<span>. The majority of women present with advanced stage, high grade disease following a period of generalised abdominal symptoms. There is currently no effective screening programme. Diagnosis is based on imaging and histology. Stratification of adnexal masses into benign and malignant categories has helped ensure appropriate patients are referred to the </span></span></span>gynaecology<span><span> oncology<span> team. The mainstay of treatment is surgery and chemotherapy, with removal of all residual disease being one of the most important </span></span>prognostic factors<span>. Recent advances in targeted therapies are also beginning to improve outcomes.</span></span></p></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics, Gynaecology and Reproductive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1751721423001720","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Ovarian, fallopian tube and primary peritoneal cancer has the poorest survival outcomes of all gynaecological malignancies. The majority of women present with advanced stage, high grade disease following a period of generalised abdominal symptoms. There is currently no effective screening programme. Diagnosis is based on imaging and histology. Stratification of adnexal masses into benign and malignant categories has helped ensure appropriate patients are referred to the gynaecology oncology team. The mainstay of treatment is surgery and chemotherapy, with removal of all residual disease being one of the most important prognostic factors. Recent advances in targeted therapies are also beginning to improve outcomes.
期刊介绍：
Obstetrics, Gynaecology and Reproductive Medicine is an authoritative and comprehensive resource that provides all obstetricians, gynaecologists and specialists in reproductive medicine with up-to-date reviews on all aspects of obstetrics and gynaecology. Over a 3-year cycle of 36 issues, the emphasis of the journal is on the clear and concise presentation of information of direct clinical relevance to specialists in the field and candidates studying for MRCOG Part II. Each issue contains review articles on obstetric and gynaecological topics. The journal is invaluable for obstetricians, gynaecologists and reproductive medicine specialists, in their role as trainers of MRCOG candidates and in keeping up to date across the broad span of the subject area.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
